Vergelijking

Pasireotid vs. Vasopressin

Twee peptiden naast elkaar — identiteit, bewijsbasis, juridische status en bekende bijwerkingen.

Identiteit

Categorie

Onderzoek (overig)

CAS-nr.

396091-73-9

geen gegevens

Molecuulmassa

1047.21 g/mol

1084.23 g/mol

Halfwaardetijd

geen gegevens

Sequentie

geen gegevens

Werkingsmechanisme

Pasireotid

Pasireotide binds more broadly than older somatostatin analogs (SSTR1/2/3/5) with particularly high affinity for SSTR5. This suppresses, among others, ACTH release in Cushing's disease and GH release in acromegaly.

Vasopressin

Vasopressin binds V1 receptors (vasoconstriction, raising vascular resistance) and V2 receptors (renal water reabsorption via aquaporin channels). This raises blood pressure and acts antidiuretically. Desmopressin is the V2-selective synthetic analog.

Bewijsbasis

Hoogste bewijs

Humane RCT

Studies

waarvan bij mensen

Geregistreerde effecten

Openstaande tegenstrijdigheden

Gedocumenteerde bijwerkingen

Juridische status

Country	Pasireotid	Vasopressin
Duitsland	Op recept	Op recept
Verenigde Staten	Op recept	Op recept

Volledige vermeldingen

Pasireotid

Volledige vermelding →

Vasopressin

Volledige vermelding →

Frequently asked questions

What is the difference between Pasireotid and Vasopressin?: Pasireotid is classified as "Onderzoek (overig)", while Vasopressin is classified as "Onderzoek (overig)". Pasireotid: Pasireotide is a multireceptor somatostatin analog binding to four of the five somatostatin receptors (especially SSTR5). It is approved for Cushing's disease and acromegaly. Vasopressin: Vasopressin (arginine vasopressin, antidiuretic hormone/ADH) is a cyclic nonapeptide hormone that regulates water balance and vascular tone. As Vasostrict it is approved to raise blood pressure in vasodilatory shock. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Pasireotid or Vasopressin?: The highest available evidence level is "Humane RCT" for Pasireotid and "Humane RCT" for Vasopressin. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Pasireotid and Vasopressin in Germany and the United States?: Duitsland: Pasireotid — Op recept, Vasopressin — Op recept. Verenigde Staten: Pasireotid — Op recept, Vasopressin — Op recept. These are factual summaries with source and review date on the individual pages.

Country

Pasireotid

Vasopressin

Duitsland

Op recept

Verenigde Staten

Op recept

Frequently asked questions

What is the difference between Pasireotid and Vasopressin?

Pasireotid is classified as "Onderzoek (overig)", while Vasopressin is classified as "Onderzoek (overig)". Pasireotid: Pasireotide is a multireceptor somatostatin analog binding to four of the five somatostatin receptors (especially SSTR5). It is approved for Cushing's disease and acromegaly. Vasopressin: Vasopressin (arginine vasopressin, antidiuretic hormone/ADH) is a cyclic nonapeptide hormone that regulates water balance and vascular tone. As Vasostrict it is approved to raise blood pressure in vasodilatory shock. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Pasireotid or Vasopressin?

The highest available evidence level is "Humane RCT" for Pasireotid and "Humane RCT" for Vasopressin. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Pasireotid and Vasopressin in Germany and the United States?

Duitsland: Pasireotid — Op recept, Vasopressin — Op recept. Verenigde Staten: Pasireotid — Op recept, Vasopressin — Op recept. These are factual summaries with source and review date on the individual pages.